NDC 0641-6035-01 - Glycopyrrolate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0641-6035
- Requested NDC
- 0641-6035-01
- Package NDCs from labels
- 0641-6035-01, 0641-6035-25
- Manufacturer
- West-ward Pharmaceutical Corp.
- Effective date
- 2012-02-09
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Glycopyrrolate Injection, USP | West-ward Pharmaceutical Corp. | 2012-02-09 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-13 | Indexing - Billing Unit |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 0641-6035-25 | 2019-11-13 | C162847 | 48780-1 | 97449f38-ba6e-f6ea-e053-dbdaa90aa703 | Glycopyrrolate Injection, USP |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0641-6035-01 | ML - Milliliter | 0641-6035 | 6ee1ffa7-8837-44b9-bf41-6de0e79f42f7 | 1 | 2013-02-13 |
| 0641-6035-25 | ML - Milliliter | 0641-6035 | b45f5ffb-a1b6-44c6-99ff-5cdd3c36bf02 | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| GLYCOPYRROLATE | ACTIVE INGREDIENT | V92SO9WP2I | GLYCOPYRROLATE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 3 | |
| GLYCOPYRROLATE | ACTIVE MOIETY | V92SO9WP2I | GLYCOPYRROLATE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 3 | |
| BENZYL ALCOHOL | INACTIVE INGREDIENT | LKG8494WBH | GLYCOPYRROLATE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 3 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | GLYCOPYRROLATE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 3 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Glycopyrrolate | GLYCOPYRROLATE | Atlantic Biologicals Corp. | 50b493d7-8e3b-e459-e063-6394a90addbc | 2026-04-30 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Gland Pharma Limited | d670bd26-8a44-44be-90e1-107d4c380233 | 2026-04-28 | Warnings, Adverse reactions | V92SO9WP2I |
| glycopyrrolate | GLYCOPYRROLATE | Amneal Pharmaceuticals LLC | 741355f5-b695-41bb-a065-4abc687312b2 | 2026-04-28 | Warnings, Adverse reactions | V92SO9WP2I |
| BREZTRI | BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE | AstraZeneca Pharmaceuticals LP | 715433dc-cb2b-43ea-b6df-c5b4177adc6c | 2026-04-27 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Sagent Pharmaceuticals | 55930f87-8964-43b1-b790-c1e6dd2602d2 | 2026-04-20 | Warnings, Adverse reactions | V92SO9WP2I |
| GLYCOPYRROLATE | GLYCOPYRROLATE | Bryant Ranch Prepack | 21c7d201-c0b8-4f16-be4a-681d0b22791e | 2026-04-03 | Warnings, Adverse reactions | V92SO9WP2I |
| KIDS TOOTHPASTE, FOR CAVITY PROTECTION | KIDS TOOTHPASTE FOR CAVITY PROTECTION | Shulisa (Foshan) Daily ChemicalIndustry Co., Ltd | 4e8fab9e-f05c-5e2f-e063-6294a90aecf9 | 2026-04-03 | Warnings | 059QF0KO0R |
| Glycopyrrolate Oral Solution | GLYCOPYRROLATE ORAL SOLUTION | Sun Pharmaceutical Industries, Inc. | e20c9a89-2a81-3c6e-e053-2995a90a9861 | 2026-04-02 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Sandoz Inc | cb1ae370-ec4f-4114-9860-8f736f72b545 | 2026-04-01 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | REMEDYREPACK INC. | a338ef22-c243-4075-b02d-bcd5b590104a | 2026-03-26 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | REMEDYREPACK INC. | fafea739-87d0-4421-833f-eb066791504c | 2026-03-26 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Lifestar Pharma LLC | 0f4a4b94-71e0-49ed-8f1e-c760e4dd3137 | 2026-03-25 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Major Pharmaceuticals | 6e5bfe6d-d321-4f0f-86e2-457d8fd10a6a | 2026-03-19 | Warnings, Adverse reactions | V92SO9WP2I |
| Sterile Water | WATER | Hospira, Inc. | 2b9ea23a-f9e9-48a8-25b7-519e3bbd6828 | 2026-03-18 | Warnings, Adverse reactions | 059QF0KO0R |
| TINTED SUNSCREEN FOUNDATION | TINTED SUNSCREEN FOUNDATION | Guanghzou AiXin Biotech Co Ltd | 396393c4-b50c-3877-e063-6294a90a0e9b | 2026-03-17 | Warnings | 059QF0KO0R |
| 2-Pack Facial Serum | 2-PACK FACIAL SERUM | Guangzhou Ariel Biotech Co., Ltd. | 27c7f645-cfb3-6db1-e063-6394a90a42ff | 2026-03-06 | Warnings | 059QF0KO0R |
| glycopyrrolate | GLYCOPYRROLATE | Bionpharma Inc. | 512d3f1e-c35c-87c2-e063-6394a90a8de0 | 2026-03-05 | Warnings, Adverse reactions | V92SO9WP2I |
| Walgreens Unscented Pain Relieving | LIDOCAINE HYDROCHLORIDE, BENZYL ALCOHOL | Walgreen Co. | 41eadb4f-2ca5-42a1-e063-6294a90ab4e2 | 2026-03-04 | Warnings | LKG8494WBH |
| 03f8aff8-4482-4210-8736-8125a77f27af | 61767a0d-c94c-44d8-b35c-316a5731a275 | 2026-03-02 | Warnings, Adverse reactions | 61767a0d-c94c-44d8-b35c-316a5731a275 | ||
| GLYCOPYRROLATE | GLYCOPYRROLATE | NCS HealthCare of KY, LLC dba Vangard Labs | 5ed930b7-a36e-4bf8-b1d1-dad238d3dd18 | 2026-02-25 | Warnings, Adverse reactions | V92SO9WP2I |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.